Navigation Links
Study Shows 80% of Adults with Peripheral Arterial Disease Go Undiagnosed
Date:3/10/2009

U.S. Peripheral Vascular Treatment Market to Grow to $4.7 Billion

VANCOUVER, March 10 /PRNewswire/ - According to iData Research, an international medical device & dental market research firm, an estimated 10 million people in the U.S. suffer from lower-limb Peripheral Arterial Disease (PAD), with less than 20% of these diagnosed by a physician. As early detection increases and more patients seek treatment, the U.S. market for peripheral vascular treatment will grow to an estimated $4.7 billion by 2015.

PAD is the formation of plaque in arterial blood vessels of the outer circulatory system. This causes damage to the arterial wall, which increases the risk of stroke. In 2008, over 4 million individuals in the U.S. had symptoms indicative of PAD, such as persistent leg cramping, numbness, fatigue and severe pain.

"Of people aged 50 to 69 with a history of smoking or diabetes, approximately 30% will manifest PAD," says Kamran Zamanian PhD., CEO of iData Research, "This will drive sales for PAD treatment devices, particularly for devices such as stents and stent-grafts, and complementary and alternative products, like embolic protection and atherectomy devices."

In 2008, the largest segment in the U.S. market for peripheral vascular devices was for stents, which represented 28.7% of the overall treatment market. The stent market will grow at double digit rates through 2015, led by an increase in early diagnoses. The U.S. government and the medical community have taken an active role in improving awareness of PAD among physicians and the general population.

iData Research provides market intelligence reports on the peripheral vascular device market, for the U.S., Europe and Japan. Watch the iData movie at: www.idataresearch.net/discoveridata.html

About iData Research

iData Research Inc. (www.idataresearch.net) is an international market research and consulting group focused on providing market intelligence for the medical device, dental and pharmaceutical industries. iData covers research in categories such as: Peripheral Vascular, Cardiovascular, CRM, Dental, Endoscopy, Imaging, Ophthalmics, Orthopedics, Patient Monitoring, Spine, Urology, Women's Health and more.

To learn more about iData's services, view their short informative Movie at: www.idataresearch.net/discoveridata.html


'/>"/>
SOURCE iData Research Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Study finds pay for performance stimulates changes in medical practice
2. Study: Doctor-patient conversations at end of life associated with lower medical expenses
3. Study tests reliability of more accurate measure of patient pain
4. New published study demonstrates over-the-counter device lowers blood pressure in diabetic patients
5. Study prompts new mandate for N.C. high schools
6. UCF study: Hyperactivity enables children with ADHD to stay alert
7. Study Links Internal Source of Aging and Skin Damage
8. Drug combination may be effective against deadly melanoma, pilot study shows
9. New Study Finds Text-Messaging Reminders Effective in Improving Adherence to Sunscreen Use
10. McMaster study sheds light on how stem cells develop into blood cells
11. United Spinal Association Report Reveals the Importance of Studying Multiple Sclerosis in Children: Developing New Insights into MS in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... , ... April 26, 2017 , ... ... to improve the profitability of ready-to-drink, high-protein beverages by helping beverage manufacturers more ... to dairy proteins, providing direct cost savings as well as more stable pricing ...
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop ... Mirroring360 Pro . This new addition to the Mirroring360 product family combines device ... business. , Mirroring360 Pro enables educators, business professionals and individuals to stream or ...
(Date:4/25/2017)... ... 25, 2017 , ... As President Trump challenges the status ... his administration could impact the employee benefits industry. James Slotnick, AVP, Government Relations, ... to make it through Congress. His discussion will focus on the current state ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like ... in a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria ... now offers this revolutionary treatment with or without a referral. , Wilckodontics ...
(Date:4/25/2017)... ... 25, 2017 , ... Buyers and sellers in the thriving multi-billion dollar cannabis ... –can’t help but be heartened by the industry’s current surge. But another thing that ... “skunk smell.” At last they can simply, safely and effectively end their aroma ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
Breaking Medicine Technology: